Cancer Family
Precursor Lymphoid Neoplasm
CI-CAN-00000327Explore in graph →
Hematologic567 active trials12 approved drugs212 evidence items
- NCIt
- C7055
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000327Explore in graph →
Clinical trials
2,154 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (286)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00482352 | Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | completed | — | 11,196 | Children's Oncology GroupNETWORK | 6 | Aug 3, 2023 | clinicaltrials |
| NCT03267186 | Ibrutinib in Preventing Acute Leukemia in Patients After Reduced-Intensity Conditioning and Stem Cell Transplant | completed | Phase 2 | 8 | Andrew RezvaniOTHER | 1 | Aug 1, 2023 | clinicaltrials |
| NCT01614197 | A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma | completed | Phase 1 | 16 | Therapeutic Advances in Childhood Leukemia ConsortiumOTHER | 3 | Jul 27, 2023 | clinicaltrials |
| NCT04007601 | Neurostimulation In Adult Survivors of Childhood Acute Lymphoblastic Leukemia (ALL) | completed | N/A | 127 | St. Jude Children's Research HospitalOTHER | 1 | Jul 27, 2023 | clinicaltrials |
| NCT03328104 | Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma(ENCERT) | completed | Phase 1 | 8 | Emory UniversityOTHER | 1 | Jul 21, 2023 | clinicaltrials |
| NCT02847130 | Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology | completed | — | 530 | Children's Oncology GroupNETWORK | 2 | Jul 19, 2023 | clinicaltrials |
| NCT02311998 | Phase I/II Study of Bosutinib in Combination With Inotuzumab Ozogamicin in CD22-positive PC Positive ALL and CML | completed | Phase 1 / Phase 2 | 22 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 17, 2023 | clinicaltrials |
| NCT04954326 | A Study Comparing the Blood Levels of Both Pegaspargase (S95014) Formulations (Liquid vs Lyophilized) in the Treatment of Paediatric Patients With Acute Lymphoblastic Leukemia (ALL)(ALL) | completed | Phase 2 | 89 | Institut de Recherches Internationales ServierOTHER | 1 | Jul 12, 2023 | clinicaltrials |
| NCT05933811 | Contralateral Testicular Volume in Unilateral Impalpable Testis | completed | N/A | 76 | Egyptian Biomedical Research NetworkNETWORK | 1 | Jul 12, 2023 | clinicaltrials |
| NCT05607355 | Measurement of Spinal Mobilization in Pediatric Population | completed | — | 47 | Université du Québec à Trois-RivièresOTHER | 1 | Jul 11, 2023 | clinicaltrials |
| NCT03991884 | Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia | completed | Phase 1 | 24 | University of WashingtonOTHER | 1 | Jul 6, 2023 | clinicaltrials |
| NCT01572662 | Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning | completed | Phase 2 | 201 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 29, 2023 | clinicaltrials |
| NCT04562792 | Low Dose Daunorubicin in Pediatric Relapsed/Refractory Acute Leukemia | completed | Phase 2 | 1 | Children's Mercy Hospital Kansas CityOTHER | 1 | Jun 28, 2023 | clinicaltrials |
| NCT01029366 | CART19 to Treat B-Cell Leukemia or Lymphoma That Are Resistant or Refractory to Chemotherapy | completed | Phase 1 | 26 | University of PennsylvaniaOTHER | 1 | Jun 22, 2023 | clinicaltrials |
| NCT02141828 | A Phase 1 Dose Escalation and Expanded Cohort Study of EPZ-5676 in the Treatment of Pediatric Patients With Relapsed/Refractory Leukemias Bearing a Rearrangement of the MLL Gene | completed | Phase 1 | 18 | Epizyme, Inc.INDUSTRY | 2 | Jun 18, 2023 | clinicaltrials |
| NCT04806100 | Effects of Malleo-Lok Stiffness on Lower Limb Mechanics(MalleoLokStiff) | completed | N/A | 20 | University of IowaOTHER | 1 | Jun 15, 2023 | clinicaltrials |
| NCT05902585 | Virtual Reality in the Management of Pain in Pediatrics: a Multi-center Randomized Clinical Trial (RealPED)(RealPED) | completed | N/A | 83 | Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat ValencianaOTHER | 1 | Jun 15, 2023 | clinicaltrials |
| NCT00287105 | Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children(ESPHALL) | completed | Phase 2 | 49 | Rennes University HospitalOTHER | 1 | May 24, 2023 | clinicaltrials |
| NCT01282593 | Potential Role of CD9 and Implication of Motility Process in Pathogenesis of TEL/ALM1-positive ALL Relapses (LAL TEL/ALM1 and CD9).(LAL TEL/ALM1) | completed | N/A | 51 | Rennes University HospitalOTHER | 1 | May 24, 2023 | clinicaltrials |
| NCT03236857 | A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies | completed | Phase 1 | 143 | AbbVieINDUSTRY | 8 | May 22, 2023 | clinicaltrials |
| NCT04357041 | COVID-19 Survey Study on Dietary Intake, Physical Activity and Overall Well-being(CoVS) | completed | — | 440 | Clinical Nutrition Research Center, Illinois Institute of TechnologyINDUSTRY | 1 | May 17, 2023 | clinicaltrials |
| NCT05130489 | CAR T Cell Therapy Related Cardiovascular Outcomes(CARTCO) | completed | — | 150 | University College London HospitalsOTHER | 1 | May 12, 2023 | clinicaltrials |
| NCT03860376 | Ex Vivo Drug Sensitivity Testing and Mutation Profiling | completed | — | 25 | Florida International UniversityOTHER | 1 | May 10, 2023 | clinicaltrials |
| NCT05455268 | Information Support Using an Online Learning Platform for Malaysian Pediatric Leukemia and Lymphoma Parents(eHOPE) | completed | N/A | 51 | Universiti Kebangsaan Malaysia Medical CentreOTHER | 1 | May 10, 2023 | clinicaltrials |
| NCT05849792 | Internet-based Physical Activities Randomized Controlled Trial in Mild/Moderate Depression Participants: SONRIE Project(SONRIE) | completed | N/A | 80 | University of CadizOTHER | 1 | May 9, 2023 | clinicaltrials |
| NCT03389035 | Transposon-manipulated Allogeneic CARCIK-CD19 Cells in Pediatric and Adult Patients With r/r ALL Post HSCT(CARCIK) | completed | Phase 1 / Phase 2 | 21 | Fondazione Matilde Tettamanti Menotti De Marchi OnlusOTHER | 1 | May 6, 2023 | clinicaltrials |
| NCT01925131 | S1312, Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Leukemia | completed | Phase 1 | 50 | SWOG Cancer Research NetworkNETWORK | 1 | May 3, 2023 | clinicaltrials |
| NCT02581007 | Reduced Intensity Conditioning Transplant Using Haploidentical Donors | completed | Phase 2 | 25 | Northside Hospital, Inc.OTHER | 1 | Apr 27, 2023 | clinicaltrials |
| NCT04067518 | A Clinical Study of SHP674 (Pegaspargase) in Participants With Newly Diagnosed, Untreated Acute Lymphoblastic Leukemia | completed | Phase 2 | 28 | Institut de Recherches Internationales ServierOTHER | 1 | Apr 20, 2023 | clinicaltrials |
| NCT01565447 | Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma Gait Parameters Study | completed | — | 109 | Oregon Health and Science UniversityOTHER | 1 | Apr 18, 2023 | clinicaltrials |
| NCT05818215 | Impact of the Qatar 2022 FIFA World Cup on PED Use and Misuse Patterns | completed | — | 18,000 | Pediatric Clinical Research PlatformOTHER | 1 | Apr 18, 2023 | clinicaltrials |
| NCT05621629 | Management of FI After Surgery of ARM | completed | — | 108 | Shengjing HospitalOTHER | 1 | Apr 12, 2023 | clinicaltrials |
| NCT05800613 | Management of Ovarian Masses in Pediatric Patients: an Italian Survey(OvaMa-PEDs) | completed | — | 60 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Apr 5, 2023 | clinicaltrials |
| NCT01256398 | Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | completed | Phase 2 | 66 | National Cancer Institute (NCI)NIH | 1 | Apr 4, 2023 | clinicaltrials |
| NCT02185781 | Phase I Study of Adoptive Immunotherapy With Enriched and Expanded Autologous Natural Killer (NK) Cells for Patients With Ph+ Acute Lymphoblastic Leukemia (ALL) | completed | Phase 1 | 6 | Gruppo Italiano Malattie EMatologiche dell'AdultoOTHER | 1 | Mar 30, 2023 | clinicaltrials |
| NCT04199637 | Evaluation of Therapeutic Video Games for Pre-school Children With Acute Lymphoblastic Leukemia | completed | N/A | 15 | National Yang Ming Chiao Tung UniversityOTHER | 1 | Mar 23, 2023 | clinicaltrials |
| NCT05779332 | Prevalence, Etiology and Effects on Oral Health and Life Quality of Molar Incisor Hypomineralization | completed | — | 655 | Recep Tayyip Erdogan University Training and Research HospitalOTHER | 1 | Mar 22, 2023 | clinicaltrials |
| NCT03109093 | Blinatumomab in Adult Patients With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia | completed | Phase 2 | 83 | Goethe UniversityOTHER | 1 | Mar 21, 2023 | clinicaltrials |
| NCT00198978 | German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | completed | Phase 4 | 377 | Goethe UniversityOTHER | 1 | Mar 20, 2023 | clinicaltrials |
| NCT00199030 | Treatment of Relapsed T-cell Acute Lymphoblastic Leukemia or T-lymphoblastic Lymphoma With MabCampath | completed | Phase 2 | 8 | Goethe UniversityOTHER | 1 | Mar 20, 2023 | clinicaltrials |
| NCT00199056 | German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (06/99) | completed | Phase 4 | 225 | Goethe UniversityOTHER | 1 | Mar 20, 2023 | clinicaltrials |
| NCT00199095 | Treatment of Elderly Patients (>65 Years) With Acute Lymphoblastic Leukemia | completed | Phase 4 | 40 | Goethe UniversityOTHER | 1 | Mar 20, 2023 | clinicaltrials |
| NCT00199043 | Treatment of Hyperuricemia With Rasburicase in Patients With Acute Lymphoblastic Leukemia or High Grade Lymphoma | completed | Phase 3 | 80 | Goethe UniversityOTHER | 1 | Mar 17, 2023 | clinicaltrials |
| NCT00199069 | German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (05/93) | completed | Phase 4 | 720 | Goethe UniversityOTHER | 1 | Mar 17, 2023 | clinicaltrials |
| NCT04323657 | TC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia | completed | Phase 1 / Phase 2 | 6 | TCR2 TherapeuticsINDUSTRY | 1 | Mar 16, 2023 | clinicaltrials |
| NCT00354120 | Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant(GLOBAL) | completed | Phase 2 / Phase 3 | 121 | Gruppo Italiano Trapianto di Midollo OsseoOTHER | 1 | Mar 10, 2023 | clinicaltrials |
| NCT04610918 | Comparing Body Composition Assessment Methods | completed | — | 70 | The Hospital for Sick ChildrenOTHER | 1 | Mar 2, 2023 | clinicaltrials |
| NCT03385681 | Pediatric Pain Management - an Intervention Study | completed | N/A | 876 | Oslo University HospitalOTHER | 1 | Feb 23, 2023 | clinicaltrials |
| NCT02890758 | Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803 | completed | Phase 1 | 14 | Brenda Cooper, MDOTHER | 1 | Feb 21, 2023 | clinicaltrials |
| NCT00796068 | Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant | completed | Phase 2 | 130 | Fred Hutchinson Cancer CenterOTHER | 1 | Feb 17, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Aug 3, 2023source: clinicaltrials